Mono Pharmacare Ltd.
•₹ 8.450.6%
2026-08-21
PROS
CONS
- Operating cash flow has been negative in recent years
- A large part of profit comes from other income (67.2% of PBT)
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -4.04x)
- Company has a low return on capital employed of 8.8%
- Company has a low return on equity of 8.7% over last 3 years
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | ADANIENT | 2979.00 | 54.17 | 403273.96 | 0.04 | -1461.54 | -249.67 | 32923.98 | 49.92 | 13.30 | 15.57 |
| 2. | AEGISLOG | 1363.65 | 38.25 | 47864.12 | 0.64 | 544.84 | 210.70 | 2356.86 | 37.07 | 19.76 | 30.28 |
| 3. | PREMIERENE | 1008.00 | 27.48 | 45758.31 | 0.10 | 471.92 | 53.32 | 2462.59 | 35.25 | 41.97 | 29.03 |
| 4. | CPPLUS | 3307.45 | 81.98 | 39127.28 | 0.05 | 142.20 | 332.51 | 1402.42 | 89.51 | 29.48 | 14.52 |
| 5. | REDINGTON | 334.90 | 15.39 | 26181.63 | 1.79 | 453.49 | 94.65 | 34922.47 | 34.57 | 18.96 | 2.03 |
| 6. | HONASA | 476.90 | 62.48 | 15548.09 | 0.63 | 90.45 | 118.87 | 755.95 | 27.00 | 8.99 | 14.58 |
| 7. | LLOYDSENT | 78.59 | 106.84 | 11997.17 | 0.19 | 109.98 | -55.77 | 563.03 | 70.15 | 12.84 | 18.07 |
| 8. | SGMART | 805.80 | 81.69 | 10155.92 | 0.00 | 455.80 | 1310.71 | 13085.70 | 1044.08 | 11.45 | 4.49 |
| 9. | MMTC | 62.10 | 20.82 | 9315.00 | 0.00 | 104.24 | 135.52 | 0.68 | -50.00 | 6.90 | -1423.53 |
| 10. | CELLO | 358.45 | 25.31 | 7917.62 | 0.42 | 73.40 | -8.99 | 526.72 | -0.43 | 17.15 | 18.80 |
| 11. | EBGNG | 588.80 | 47.13 | 6713.00 | 0.00 | 289.30 | 1462.10 | 4124.61 | 1220.81 | 20.14 | 11.97 |
| 12. | MONOPHARMA | 8.20 | 41.04 | 14.49 | 0.00 | — | — | — | — | 11.00 | — |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
No standalone quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 14 | 71 | 83 | |
| 13 | 68 | 80 | |
| Operating Profit | 1 | 4 | 5 |
| OPM % | 8 | 6 | 6 |
| Other Income | 0 | 2 | 3 |
| Interest | 0 | 1 | 1 |
| Depreciation | 0 | 0 | 0 |
| 1 | 3 | 4 | |
| Tax % | 19 | 14 | 18 |
| Net Profit | 1 | 2 | 3 |
| EPS | 1 | 1 | 2 |
| Dividend Payout % | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 |
| Adjusted EPS | 0 | 1 | 2 |
| Minority Interest | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 |
| Adjusted EPS | 0 | 1 | 2 |
Mar 2023
- 14
- 13
- Operating Profit
- 1
- OPM %
- 8
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 19
- Net Profit
- 1
- EPS
- 1
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2024
- 71
- 68
- Operating Profit
- 4
- OPM %
- 6
- Other Income
- 2
- Interest
- 1
- Depreciation
- 0
- 3
- Tax %
- 14
- Net Profit
- 2
- EPS
- 1
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2025
- 83
- 80
- Operating Profit
- 5
- OPM %
- 6
- Other Income
- 3
- Interest
- 1
- Depreciation
- 0
- 4
- Tax %
- 18
- Net Profit
- 3
- EPS
- 2
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -66%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 9%
- Last Year:
- 10%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| LIABILITIES | - | - | - |
| Equity Capital | 12 | 18 | 18 |
| 1 | 10 | 14 | |
| 9 | 9 | 10 | |
| Trade Payables | 2 | 3 | 9 |
| 4 | 5 | 15 | |
| Total Liabilities | 29 | 45 | 66 |
| ASSETS | - | - | - |
| 2 | 4 | 11 | |
| 15 | 21 | 28 | |
| 0 | 17 | 19 | |
| 11 | 3 | 8 | |
| Total Assets | 29 | 45 | 66 |
| Total Debt | 13 | 13 | 24 |
| Net Working Capital | 15 | 29 | 34 |
| Contingent Liabilities | 0 | 0 | 0 |
| Book Value per Share | 10.83 | 15.91 | 17.66 |
| Face Value | 10.00 | 10.00 | 10.00 |
| Total Debt | 13 | 13 | 24 |
| Net Working Capital | 15 | 29 | 34 |
| Contingent Liabilities | 0 | 0 | 0 |
| Book Value per Share | 10.83 | 15.91 | 17.66 |
| Face Value | 10.00 | 10.00 | 10.00 |
Mar 2023
- Equity Capital
- 12
- 1
- 9
- Trade Payables
- 2
- 4
- Total Liabilities
- 29
- 2
- 15
- 0
- 11
- Total Assets
- 29
- Total Debt
- 13
- Net Working Capital
- 15
- Contingent Liabilities
- 0
- Book Value per Share
- 10.83
- Face Value
- 10.00
- Total Debt
- 13
- Net Working Capital
- 15
- Contingent Liabilities
- 0
- Book Value per Share
- 10.83
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 18
- 10
- 9
- Trade Payables
- 3
- 5
- Total Liabilities
- 45
- 4
- 21
- 17
- 3
- Total Assets
- 45
- Total Debt
- 13
- Net Working Capital
- 29
- Contingent Liabilities
- 0
- Book Value per Share
- 15.91
- Face Value
- 10.00
- Total Debt
- 13
- Net Working Capital
- 29
- Contingent Liabilities
- 0
- Book Value per Share
- 15.91
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 18
- 14
- 10
- Trade Payables
- 9
- 15
- Total Liabilities
- 66
- 11
- 28
- 19
- 8
- Total Assets
- 66
- Total Debt
- 24
- Net Working Capital
- 34
- Contingent Liabilities
- 0
- Book Value per Share
- 17.66
- Face Value
- 10.00
- Total Debt
- 24
- Net Working Capital
- 34
- Contingent Liabilities
- 0
- Book Value per Share
- 17.66
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| -13 | -10 | -1 | |
| Cash from Investing | -2 | -2 | -7 |
| Cash from Financing | 16 | 12 | 8 |
| 0 | 0 | -0 | |
| Free Cash Flow | -13 | -10 | -1 |
| OCF / Net Profit | -24.90 | -4.22 | -0.24 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
| OCF / Net Profit | -24.90 | -4.22 | -0.24 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
Mar 2023
- -13
- Cash from Investing
- -2
- Cash from Financing
- 16
- 0
- Free Cash Flow
- -13
- OCF / Net Profit
- -24.90
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -24.90
- Cumulative 5-Year FCF
- 0
Mar 2024
- -10
- Cash from Investing
- -2
- Cash from Financing
- 12
- 0
- Free Cash Flow
- -10
- OCF / Net Profit
- -4.22
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -4.22
- Cumulative 5-Year FCF
- 0
Mar 2025
- -1
- Cash from Investing
- -7
- Cash from Financing
- 8
- -0
- Free Cash Flow
- -1
- OCF / Net Profit
- -0.24
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.24
- Cumulative 5-Year FCF
- 0
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| PER SHARE | - | - | - |
| EPS (₹) | 0.44 | 1.38 | 1.75 |
| Book Value (₹) | 10.83 | 15.91 | 17.66 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 0.46 | 1.43 | 1.80 |
| PROFITABILITY | - | - | - |
| Operating Margin % | 7.66% | 3.47% | 3.10% |
| Net Margin % | 3.89% | 3.45% | 3.74% |
| ROE % | 4.04% | 11.77% | 10.42% |
| ROCE % | 4.03% | 12.10% | 10.42% |
| 1.87% | 6.56% | 5.55% | |
| EFFICIENCY | - | - | - |
| Debtor Days | 212 | 66 | 80 |
| Inventory Days | 398 | 93 | 108 |
| Payable Days | 64 | 14 | 30 |
| 546 | 145 | 158 | |
| FINANCIAL HEALTH | - | - | - |
| Debt to Equity (x) | 0.93x | 0.47x | 0.76x |
| Interest Coverage (x) | 2.76x | 3.35x | 4.04x |
| 2.19x | 3.22x | 2.59x | |
| GROWTH | - | - | - |
| Revenue Growth % | 0.00% | 408.19% | 16.86% |
| Operating Profit Growth % | 0.00% | 288.97% | 22.92% |
| Net Profit Growth % | 0.00% | 350.79% | 26.52% |
| 0.00% | 215.59% | 26.53% | |
| VALUATION | - | - | - |
| P/E (x) | 0.00x | 31.90x | 13.21x |
| P/B (x) | 0.00x | 2.77x | 1.31x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% |
| 0.00x | 21.92x | 12.63x |
Mar 2023
- EPS (₹)
- 0.44
- Book Value (₹)
- 10.83
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.46
- Operating Margin %
- 7.66%
- Net Margin %
- 3.89%
- ROE %
- 4.04%
- ROCE %
- 4.03%
- 1.87%
- Debtor Days
- 212
- Inventory Days
- 398
- Payable Days
- 64
- 546
- Debt to Equity (x)
- 0.93x
- Interest Coverage (x)
- 2.76x
- 2.19x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 1.38
- Book Value (₹)
- 15.91
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 1.43
- Operating Margin %
- 3.47%
- Net Margin %
- 3.45%
- ROE %
- 11.77%
- ROCE %
- 12.10%
- 6.56%
- Debtor Days
- 66
- Inventory Days
- 93
- Payable Days
- 14
- 145
- Debt to Equity (x)
- 0.47x
- Interest Coverage (x)
- 3.35x
- 3.22x
- Revenue Growth %
- 408.19%
- Operating Profit Growth %
- 288.97%
- Net Profit Growth %
- 350.79%
- 215.59%
- P/E (x)
- 31.90x
- P/B (x)
- 2.77x
- Dividend Yield %
- 0.00%
- 21.92x
Mar 2025
- EPS (₹)
- 1.75
- Book Value (₹)
- 17.66
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 1.80
- Operating Margin %
- 3.10%
- Net Margin %
- 3.74%
- ROE %
- 10.42%
- ROCE %
- 10.42%
- 5.55%
- Debtor Days
- 80
- Inventory Days
- 108
- Payable Days
- 30
- 158
- Debt to Equity (x)
- 0.76x
- Interest Coverage (x)
- 4.04x
- 2.59x
- Revenue Growth %
- 16.86%
- Operating Profit Growth %
- 22.92%
- Net Profit Growth %
- 26.52%
- 26.53%
- P/E (x)
- 13.21x
- P/B (x)
- 1.31x
- Dividend Yield %
- 0.00%
- 12.63x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Nothing filed yet.